Characterization and Treatment of Recurrent Bacterial Vaginosis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Bacterial vaginosis (BV) is a common but treatable condition, with a number of effective available treatments, including oral and intravaginal metronidazole and clindamycin and oral tinidazole. However, as many as 50% of women with BV experience recurrence within 1 year of treatment for incident disease. Some reasons for recurrence include the persistence of residual infection, resistance, and possibly reinfection from either male or female partners. Persistence may occur due to the formation of a biofilm that protects BV-causing bacteria from antimicrobial therapy. Poor adherence to treatment among patients with genitourinary infections may lead to resistance. However, the underlying mechanisms of recurrent etiology of BV are not known. Recommended treatment for recurrent BV consists of an extended course of metronidazole treatment (500 mg twice daily for 10-14 days); if ineffective, metronidazole vaginal gel 0.75% for 10 days, followed by two times per week for 3-6 months, is an alternate treatment regimen. Past studies of clindamycin and tinidazole in the treatment of recurrent BV have focused on patients with evidence of metronidazole resistance. Secnidazole may be an attractive new option due to one-time dosing. Initial studies on biofilm disruption, use of probiotics and prebiotics, and botanical treatments have shown some promise, but must be studied further before use in the clinic. Despite limitations, antimicrobial therapy will remain the mainstay of treatment for recurrent BV for the foreseeable future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant
Hillier, S. L., Nugent, R. P., Eschenbach, D. A., Krohn, M. A., Gibbs, R. S., Martin, D. H., Cotch, M. F., Edelman, R., Pastorek, J. G., Rao, A. V., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512283332604 · Cited by 1,492
Current Treatment of Bacterial Vaginosis—Limitations and Need for Innovation
Bradshaw, C. S., & Sobel, J. D. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw159 · Cited by 245
DNase Inhibits Gardnerella vaginalis Biofilms In Vitro and In Vivo
Hymes, S. R., Randis, T. M., Sun, T. Y., & Ratner, A. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit047 · Cited by 96
Bradshaw, C. S., Walker, J., Fairley, C. K., Chen, M. Y., Tabrizi, S. N., Donovan, B., Kaldor, J. M., McNamee, K., Urban, E., Walker, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057688 · Cited by 95
Tan, H., Fu, Y., Yang, C., & Ma, J. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4366-0 · Cited by 44
Cited by
Ravel, J., Moreno, I., & Simón, C. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.019 · Cited by 370
Bacterial vaginosis: A state of microbial dysbiosis
Mondal, A. S., Sharma, R., & Trivedi, N. (2023) · Medicine in Microecology · doi:10.1016/j.medmic.2023.100082 · Cited by 44
Nayak, R., Halder, J., Rajwar, T. K., Pradhan, D., Dash, P., Das, C., Rai, V. K., Kar, B., Ghosh, G., & Rath, G. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106494 · Cited by 15
Zeng, X., An, R., & Li, H. (2023) · Open Medicine · doi:10.1515/med-2023-0743 · Cited by 10
“However, the definition of recurrent bacterial vaginosis (RBV) is still not widely accepted; yet, generally, it is defined as a confirmed diagnosis of BV three or more times within the same year [1].”
BackgroundResult
Metadata
- Authors
- Faught, B. M., & Reyes, S.
- Venue
- Journal of Women's Health
- Publisher
- SAGE Publications
- Published
- 2019-09-01
- Volume
- 28
- Issue
- 9
- Pages
- 1218-1226
- ISSN
- 1059-7115 (ISSN-L)
- 1540-9996
- 1931-843X
- OpenAlex
- W2969075971
- Cited by
- 96
- References
- 6
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterization and Treatment of Recurrent Bacterial Vaginosis. https://app.cochat.ai/papers/10.1089/jwh.2018.7383
- The paper
- Faught, B. M., & Reyes, S. (2019). Characterization and Treatment of Recurrent Bacterial Vaginosis. Journal of Women's Health. https://doi.org/10.1089/jwh.2018.7383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.